EQUITY-BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2017

Equity-based compensation

Schedule of equity-based compensation expense

Equity-based compensation expense included in Corporate General and Administrative expenses in the Condensed Consolidated Statements of Operations for the three months ended March 31, 2017 and 2016 was as follows (in thousands):

	For the Three Months Ended March 31,
	2017		2016
Stock options	$	—	$	55
Time-based restricted stock	476		337
Performance-based restricted stock	634		381
Director stock	20		20
	$	1,130	$	793

Schedule of unrecognized equity-based compensation expense for all non-vested awards

Unrecognized equity-based compensation expense for all non-vested awards pursuant to our Equity Plan was $10.1 million at March 31, 2017 as follows (in thousands):

	Total		2017		2018		2019		2020		2021
Time-based restricted stock	$	4,106	$	1,591	$	1,493	$	839	$	173	$	10
Performance-based restricted stock	6,005		2,415		2,196		1,223		171		—
	$	10,111	$	4,006	$	3,689	$	2,062	$	344	$	10

Restricted Stock Awards | Time-Based

Equity-based compensation

Schedule of restricted stock awards

The following table summarizes time-based restricted stock award activity under our Equity Plan for the three months ended March 31, 2017:

	Number  of Shares		Weighted Average Grant Date  Fair Value		Aggregate Current Value
			(per share)		(in thousands)
Non-vested at December 31, 2016	357,845		$	11.90	$	5,736
Granted	136,103		15.39
Vested	(74,588	)	12.19
Non-vested at March 31, 2017	419,360		$	12.98	$	6,701

Restricted Stock Awards | Performance-Based

Equity-based compensation

Schedule of restricted stock awards

The following table summarizes performance-based restricted stock activity under the Equity Plan for the three months ended March 31, 2017:

	Number  of Shares		Weighted Average Grant Date  Fair Value (1)		Aggregate Current Value
			(per share)		(in thousands)
Non-vested at December 31, 2016	449,027		$	14.90	$	7,198
Granted	180,039		17.13
Vested	(39,959	)	7.12
Non-vested at March 31, 2017	589,107		$	16.11	$	9,414

(1) The amounts included in this column represent the expected future value of the performance-based restricted stock awards calculated using the Monte Carlo simulation valuation model.